{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:32:20Z","timestamp":1760783540729},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1212\/wnl.50.4.1067","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:33:19Z","timestamp":1336915999000},"page":"1067-1073","source":"Crossref","is-referenced-by-count":9,"title":["Charcot-Marie-Tooth disease and Noonan syndrome with giant proximal nerve hypertrophy"],"prefix":"10.1212","volume":"50","author":[{"given":"P. A.","family":"Silburn","sequence":"first","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Nicholson","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. T.","family":"Teh","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. P.","family":"Blair","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Pollard","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Nolan","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Larsson","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S.","family":"Boyle","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (Drs. Silburn and Boyle), Princess Alexandra Hospital, Brisbane, Australia; the Department of Neurology(Dr. Nicholson), Concord Hospital, Sydney, Australia; the Department of Molecular Medicine, (Drs. Teh and Larsson), Karolinska Hospital, CMM, Stockholm, Sweden; the Department of Neurology (Dr. Pollard), Royal Prince Alfred Hospital, Sydney, Australia; and the Department of Respiratory Medicine (Dr. Nolan), The Prince Charles Hospital, Brisbane, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.24.1.9"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-3"},{"key":"e_1_3_1_4_2","first-page":"5","volume":"45","year":"1988","unstructured":"Stumpf S, Alksne JF, Annergers JF, et al. Neurofibromatosis Conference statement. Arch Neurol 1988;45:575-578.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_5_2","first-page":"1","volume":"29","year":"1992","unstructured":"Stern HJ, Saal HM, Lee JS, et al. Clinical variability of type 1 neurofibromatosis: Is there a neurofibromatosis-Noonan syndrome? J Med Genet 1992;29:184-187.","journal-title":"Clinical variability of type 1 neurofibromatosis: Is there a neurofibromatosis-Noonan syndrome? J Med Genet"},{"key":"e_1_3_1_6_2","first-page":"4","volume":"21","year":"1985","unstructured":"Opitz JM, Weaver DD. Editorial comment: the neurofibromatosis-Noonan syndrome. Am J Med Genet 1985;21:477-490.","journal-title":"Am J Med Genet"},{"key":"e_1_3_1_7_2","first-page":"9","volume":"53","year":"1993","unstructured":"Tassabehji M, Strachan T, Sharland M, et al. Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with feature of Watson syndrome and Noonan syndrome. Am J Hum Genet 1993;53:90-95.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_8_2","first-page":"4","volume":"54","year":"1994","unstructured":"Kayes LM, Burke W, Riccardi VM, et al. Deletion spanning the Neurofibromatosis gene: identification and phenotype of five patients. Am J Hum Genet 1994;54:424-436.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_9_2","first-page":"5","volume":"49","year":"1996","unstructured":"Colley A, Donnai D, Evans DGR. Neurofibromatosis\/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet 1996;49:59-64.","journal-title":"Clin Genet"},{"key":"e_1_3_1_10_2","first-page":"5","volume":"58","year":"1995","unstructured":"Nicholson GA. Myelin gene dosage and mutation in the hereditary motor and sensory neuropathies: a review. J Neurol Neurosurg Psychiatry 1995;58:523-526.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"20","year":"1972","unstructured":"Ohnishi A, Nada O. Ultrastructure of the onion bulb like structure observed in the sural nerve in a case of von Recklinghausen's disease. Acta Neuropathol (Berl) 1972;20:258-263.","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_3_1_12_2","first-page":"5","volume":"97","year":"1974","unstructured":"Bradley WG, Richardson J, Frew IJC. The familial association of neurofibromatosis, peroneal muscle atrophy, congenital deafness, partial albinism and Axenfelds defect. Brain 1974;97:521-532.","journal-title":"Brain"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.1.1"},{"key":"e_1_3_1_14_2","first-page":"9","volume":"13","year":"1990","unstructured":"Thomas PK, King RHM, Chiang TR, et al. Neurofibromatosis neuropathy. Muscle Nerve 1990;13:93-101.","journal-title":"Muscle Nerve"},{"key":"e_1_3_1_15_2","unstructured":"Watt JL Stephen GS. In: Rooney DE Czepulkowski BH eds. Human cytogenetics-a practical approach. Washington DC: IRL Press 1986:46-52."},{"key":"e_1_3_1_16_2","first-page":"2","volume":"66","year":"1991","unstructured":"Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.","journal-title":"Cell"},{"key":"e_1_3_1_17_2","first-page":"4","volume":"58","year":"1996","unstructured":"Blair IP, Nash J, Gordon MJ, Nicholson GA. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease Type 1A: first report of a de novo duplication with a maternal origin. Am J Hum Genet 1996;58:472-476.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_18_2","first-page":"3","volume":"19","year":"1991","unstructured":"Xu G, Nelson L, O'Connell P, White R. An Alu polymorphism intragenic to the neurofibromatosis type gene (NF1). Nucleic Acids Res 1991;19:3764.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_1_19_2","first-page":"3","volume":"93","year":"1994","unstructured":"Lazaro C, Gaona A, Estivill X. Two CA\/GT repeat polymorphisms in intron 27 of the human neurofibromatosis type 1 (NF1) gene. Hum Genet 1994;93:351-352.","journal-title":"Hum Genet"},{"key":"e_1_3_1_20_2","first-page":"4","volume":"92","year":"1993","unstructured":"Lazaro C, Gaona A, Xu G, et al. A highly informative CA\/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1(NF1) gene. Hum Genet 1993;92:429-430.","journal-title":"Hum Genet"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90229-8"},{"key":"e_1_3_1_22_2","first-page":"1","volume":"249","year":"1990","unstructured":"Wallace MR, Marchuk DA, Andersen LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990;249:181-186.","journal-title":"Science"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.68.1_Spec_No.1"},{"key":"e_1_3_1_24_2","first-page":"1","volume":"19","year":"1997","unstructured":"Singer ST, Hurst D, Addiego JE. Bleeding disorder in Noonan syndrome-three case reports and review of the literature. J Pediatr Hematol Oncol 1997;19:130-134.","journal-title":"J Pediatr Hematol Oncol"},{"key":"e_1_3_1_25_2","first-page":"8","volume":"130","year":"1997","unstructured":"Badermeunier B, Tchernia G, Mielot F, et al. Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997;130:885-889.","journal-title":"J Pediatr"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002470050050"},{"key":"e_1_3_1_27_2","unstructured":"Dyck PJ Chance P Lebo R Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ Thomas PK eds. Peripheral neuropathy 3rd ed. Philadelphia: W.B. Saunders 1993:1094-1136."},{"key":"e_1_3_1_28_2","first-page":"6","volume":"24","year":"1988","unstructured":"Cusimano MD, Bilbao JM, Cohen SM. Hypertrophic brachial plexus neuritis: a pathological study of two cases. Ann Neurol 1988;24:615-622.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_29_2","first-page":"3","volume":"90","year":"1965","unstructured":"Adams RD, Ashbury AK, Michelson JI. Multifocal pseudohypertrophic neuropathy. Trans Am Neurol Assoc 1965;90:30-34.","journal-title":"Trans Am Neurol Assoc"},{"key":"e_1_3_1_30_2","first-page":"7","volume":"37","year":"1974","unstructured":"Hawkes CH, Jefferson JM, Jones EL, Smith TW. Hypertrophic mononeuropathy. J Neurol Neurosurg Psychiatry 1974;37:76-81.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_31_2","first-page":"1","volume":"23","year":"1971","unstructured":"Olsson Y. Studies on vascular permeability of peripheral nerves. 4. Distribution of intravenously injected protein tracers in the peripheral nervous system of various species. Acta Neuropathol (Berl) 1971;23:105-111.","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(78)90224-1"},{"key":"e_1_3_1_33_2","unstructured":"Pollard JD Peripheral neuropathy in diseases of thyroid and pituitary glands. In: Dyck PJ Thomas PK eds. Peripheral neuropathy 3rd ed. Philadelphia: W.B. Saunders 1993:1266-1274."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.50.4.1067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:41:59Z","timestamp":1711640519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.50.4.1067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1212\/WNL.50.4.1067"],"URL":"https:\/\/doi.org\/10.1212\/wnl.50.4.1067","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}